Drugs / SPF 50 Y51 002
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02802930 | Apr 2015 | — | Bayer | Completed | No outcome recorded |
| — | NCT02872220 | Mar → May 2015 | photoallergic dermatitis | Bayer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPF 50 Y51 002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02872220 ↗ |
| Known as | BAY987519 | “SPF 50 Y51 002 (BAY987519)” NCT02802930 ↗1“SPF 50 Y51 002 (BAY987519)” NCT02872220 ↗ |
| Route | Topical | “Application of 200 µL in an occlusive patch” NCT02802930 ↗ |